If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...

Incyte (Nasdaq:INCY) today reports 2023 second quarter financial results, and provides a status update on the Company's clinical development portfolio. "We delivered ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Abstract: Robust multiobjective optimization problems (RMOPs) widely exist in real-world applications, which introduce a variety of uncertainty in optimization models. While some evolutionary ...